Pharmacy Law Archives | Frier Levitt

Failure to Verify Prescriber’s State License Via Computer System Leads to DOJ Action

Martha M. Rumore Pharm.D., Esq., Kendra E. Pannitti, Esq. and Daniel G. Giaquinto, Esq. January 12, 2021

The Department of Justice (“DOJ” or the “Government”) and Bartell Drug, Inc. (“Bartell”), a Washington State pharmacy chain of approximately 70 pharmacies, recently reached a civil settlement in which Bartell agreed to pay a fine... Read More

Legal and Regulatory Issues in Self-Care Pharmacy Practice

Martha M. Rumore Pharm.D., Esq. January 4, 2021

Frier Levitt Clinician-Attorney and Senior Counsel, Martha M. Rumore, Pharm.D., MS, JD, LLM authored Chapter 4 of Handbook of Nonprescription Drugs titled "Legal and Regulatory Issues in Self-Care Pharmacy Practice" , 20th ed. This is an... Read More

Blogs & Articles | Life Sciences | Pharmacy Law

Frier Levitt Successfully Obtains a $6.25 Million Settlement on Behalf of Its Plan Sponsor Client Against a Pharmacy Benefits Manager

Christopher Caltavuturo, Esq., Dae Y. Lee, Esq., Pharm.D CPBS and Todd Mizeski, Esq. December 23, 2020

Frier Levitt recently obtained a $6.25 Million settlement against a Pharmacy Benefits Manager(“PBM”) on behalf of its Plan Sponsor client (“Plan”). The Plan contracted with the PBM to administer its prescription drug program, and to... Read More

Opioid Distribution Chain Participants Targeted by DOJ

Dae Y. Lee, Esq., Pharm.D CPBS, Kendra E. Pannitti, Esq. and Danielle N. DelGrosso, Esq. December 21, 2020

As the opioid crisis continues to result in devastating consequences throughout the country, the U.S. Department of Justice (the “DOJ”) is broadening its opioid enforcement to all stakeholders involved in the opioid supply chain including,... Read More

Blogs & Articles | Community, Retail Pharmacies | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

Master the Margin – Pharmacy Influencer Series: Trends in Reimbursement Solutions

Jesse C. Dresser, Esq. December 18, 2020

Frier Levitt Life Sciences Partner, Jesse C. Dresser, Esq. participated in a Master the Margin webinar with Ollin Sykes, CPA and Scotty Sykes, CPA, CFP® , both of Sykes & Company, P.A. to discuss recent trends in reimbursement... Read More

Community, Retail Pharmacies | DIR Fees | Life Sciences | Pharmacy Law | Webinars

States and Independent Pharmacies Achieve Monumental Victory in the Supreme Court

Todd Mizeski, Esq., Lucas W. Morgan, Esq. and A.J. Barbarito, Esq. December 10, 2020

On Thursday December 10, 2020, the Supreme Court of the United States (SCOTUS) issued a unanimous decision in the case Rutledge v. PCMA ruling in favor of the Petitioner, Leslie Rutledge, the Attorney General of Arkansas, and against the... Read More

Blogs & Articles | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law

PLAN SPONSOR UPDATE: Newly Announced Medicare Part D Rebate Rule Is Missing Key Components

Dae Y. Lee, Esq., Pharm.D CPBS and Jonathan E. Levitt, Esq. December 8, 2020

On November 20, 2020, the Trump administration announced plans to scrap the Medicare Part D “rebate safe harbor,” which currently permits insurance middlemen called Pharmacy Benefits Managers (“PBMs”) to charge manufacturers substantial fees... Read More

Blogs & Articles | Industry | Life Sciences | Pharmacy Law | Plan Sponsor PBM Contract Services

Compounded Bioidentical Hormone Therapy (cBHT)- FDA Ban Anticipated

Martha M. Rumore Pharm.D., Esq., Jesse C. Dresser, Esq. and Jonathan E. Levitt, Esq. December 7, 2020

Compounding pharmacies should be aware of recent developments in the law surrounding bioidentical hormone therapy (cBHT). In the field of pharmacy, compounding (performed in compounding pharmacies) is preparation of a custom formulation of a... Read More

Blogs & Articles | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA | Traditional Compounding Pharmacies (503A)

Recent HHS Announcement Further Expands Access to Telehealth, But Does CMS’ Final Rule Do the Same?

Jonian Rafti, Esq. and Arielle T. Miliambro, Esq. December 4, 2020

HHS Permits Out-of-State Telehealth Providers to Render Certain Services Nationwide On December 3, 2020, the Department of Health and Human Services (“HHS”) announced a fourth amendment to its declaration under the Public Readiness and... Read More

Blogs & Articles | COVID-19 Resources | Healthcare | Telehealth and Telemedicine

PBM Licensure and Regulation Model Act

Martha M. Rumore Pharm.D., Esq., Jesse C. Dresser, Esq. and Jonathan Levitt November 30, 2020

The current United States marketplace for the regulation of pharmacy benefits is a patchwork of inconsistent (and in some cases non-existent) state laws, state and federal agency regulations, agency manuals and federal laws. Uniform state laws would... Read More

Blogs & Articles | Defending Pharmacies in PBM Audits | Life Sciences | Plan Sponsor PBM Contract Services

Category: Pharmacy Law